MT-1 10mg

ACTIVE HALF-LIFE Several Minutes
CLASSIFICATION α-Melanocyte-Stimulating Hormone Analogue
DOSAGE 5 mg/day
ACNE No
WATER RETENTION No
HBR No
HEPATOTOXICITY No
AROMATIZATION No
MANUFACTURER Beligas
WAREHOUSE International Warehouse 3
SUBSTANCE Melanocyte-stimulating hormone (MSH) ,

Melanotan 1 is a synthetic form of the melanocyte-stimulating hormone (α-MSH), which promotes skin pigmentation by stimulating melanogenesis, the process of melanin production. Melanin serves as a protective barrier for skin cells by absorbing, reflecting, and refracting light, which helps prevent cellular damage. By promoting the production of dark protective melanin, Melanotan aids in reducing sun damage to skin exposed to UV radiation.

Recommended dosage ranges from 250 mcg to 2 mg.

Melanotan encourages the production of eumelanin (black/brown) more than pheomelanin. Administering this linear amino acid peptide, Melanotan 1, allows for enhanced tanning capabilities beyond normal physiological levels.

Melanotan peptides have a short half-life, and afamelanotide is currently being developed as an implant for easier application in dermatology. This implant releases the peptide in a controlled manner, impacting melanin density over several months. Melanotan 1 is available online in research peptide form for frequent low-dose subcutaneous injections.

Melanocortins might become a significant advancement in cosmetic treatments akin to Viagra and Botox. Melanotan can be used continuously as well as intermittently.

Intermittent therapy lasting from 10 days for skin type III to 6 months for skin type I is effective. It’s important to monitor how long melanin density remains elevated after Melanotan administration.

In Melanotan 1 production, two amino acids from the body’s natural α-MSH have been modified to enhance stability. This peptide is effective only when injected subcutaneously.

Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2

Melanotan is still in the clinical trial phase and has not yet been approved. Users engage with it under the understanding that it is intended for research purposes only. Some individuals may experience mild nausea and flushing after subcutaneous injection, but these effects are generally transient.

Safe and regulated administration of afamelanotide for research purposes resembles that of Melanotan 2. Melanotan 1 is available as a peptide in multi-dose sterile vials. Other forms such as implants, nasal sprays, or pills are not currently deemed effective.

Compared to its counterpart Melanotan 2, Melanotan 1 is less effective for achieving a dark tan, necessitating a dosage of 8-10 times higher to achieve similar results. Users of Melanotan 1 seek minimal side effects while emphasizing photoprotection. Patience and preparation are recommended throughout the Melanotan experience.

Melanotan therapy can help users develop a protective tan. Natural tanning occurs as a response to UV-induced cellular damage. Ultraviolet rays penetrate the skin’s outer layers, activating α-MSH and stimulating melanin production. The resulting melanin acts as a natural cellular sunblock. Melanotan injections may provide a safer way to achieve a cosmetic tan with reduced skin damage.

Please note that the information on this website is not a substitute for professional medical advice and is not intended for the diagnosis, treatment, cure, or prevention of any disease.